nodes	percent_of_prediction	percent_of_DWPC	metapath
Halofantrine—CYP2D6—Alzheimer's disease	0.381	1	CbGaD
Halofantrine—CYP2D6—Rivastigmine—Alzheimer's disease	0.122	0.264	CbGbCtD
Halofantrine—CYP2D6—Donepezil—Alzheimer's disease	0.0977	0.211	CbGbCtD
Halofantrine—CYP3A4—Rivastigmine—Alzheimer's disease	0.0777	0.168	CbGbCtD
Halofantrine—CYP2D6—Galantamine—Alzheimer's disease	0.0629	0.136	CbGbCtD
Halofantrine—CYP3A4—Donepezil—Alzheimer's disease	0.0621	0.134	CbGbCtD
Halofantrine—CYP3A4—Galantamine—Alzheimer's disease	0.04	0.0865	CbGbCtD
Halofantrine—Altered state of consciousness—Memantine—Alzheimer's disease	0.00409	0.0294	CcSEcCtD
Halofantrine—Lumefantrine—CYP2D6—Alzheimer's disease	0.00408	1	CrCbGaD
Halofantrine—Rigors—Memantine—Alzheimer's disease	0.00231	0.0166	CcSEcCtD
Halofantrine—Rigors—Rivastigmine—Alzheimer's disease	0.00226	0.0162	CcSEcCtD
Halofantrine—Cerebrovascular accident—Galantamine—Alzheimer's disease	0.00199	0.0143	CcSEcCtD
Halofantrine—Depressed level of consciousness—Memantine—Alzheimer's disease	0.00182	0.0131	CcSEcCtD
Halofantrine—Abnormal vision—Donepezil—Alzheimer's disease	0.00181	0.013	CcSEcCtD
Halofantrine—Orthostatic hypotension—Galantamine—Alzheimer's disease	0.00178	0.0128	CcSEcCtD
Halofantrine—Pulmonary oedema—Memantine—Alzheimer's disease	0.00168	0.0121	CcSEcCtD
Halofantrine—Haemolytic anaemia—Donepezil—Alzheimer's disease	0.00167	0.012	CcSEcCtD
Halofantrine—Abnormal vision—Memantine—Alzheimer's disease	0.00165	0.0118	CcSEcCtD
Halofantrine—Pulmonary oedema—Rivastigmine—Alzheimer's disease	0.00164	0.0118	CcSEcCtD
Halofantrine—Abnormal vision—Rivastigmine—Alzheimer's disease	0.00161	0.0116	CcSEcCtD
Halofantrine—Sleep disorder—Memantine—Alzheimer's disease	0.00158	0.0114	CcSEcCtD
Halofantrine—Pollakiuria—Galantamine—Alzheimer's disease	0.00156	0.0112	CcSEcCtD
Halofantrine—Sleep disorder—Rivastigmine—Alzheimer's disease	0.00155	0.0111	CcSEcCtD
Halofantrine—Cerebrovascular accident—Donepezil—Alzheimer's disease	0.00154	0.0111	CcSEcCtD
Halofantrine—Face oedema—Donepezil—Alzheimer's disease	0.00146	0.0105	CcSEcCtD
Halofantrine—Cerebrovascular accident—Memantine—Alzheimer's disease	0.0014	0.01	CcSEcCtD
Halofantrine—Orthostatic hypotension—Donepezil—Alzheimer's disease	0.00138	0.0099	CcSEcCtD
Halofantrine—Cerebrovascular accident—Rivastigmine—Alzheimer's disease	0.00137	0.00983	CcSEcCtD
Halofantrine—Abdominal distension—Donepezil—Alzheimer's disease	0.00131	0.00943	CcSEcCtD
Halofantrine—Visual impairment—Galantamine—Alzheimer's disease	0.0013	0.00932	CcSEcCtD
Halofantrine—Face oedema—Rivastigmine—Alzheimer's disease	0.00129	0.0093	CcSEcCtD
Halofantrine—Tinnitus—Galantamine—Alzheimer's disease	0.00126	0.00902	CcSEcCtD
Halofantrine—Orthostatic hypotension—Memantine—Alzheimer's disease	0.00125	0.00899	CcSEcCtD
Halofantrine—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.00123	0.00879	CcSEcCtD
Halofantrine—Pollakiuria—Donepezil—Alzheimer's disease	0.00121	0.00865	CcSEcCtD
Halofantrine—Arrhythmia—Galantamine—Alzheimer's disease	0.0012	0.00864	CcSEcCtD
Halofantrine—Back pain—Galantamine—Alzheimer's disease	0.00114	0.00815	CcSEcCtD
Halofantrine—Pollakiuria—Memantine—Alzheimer's disease	0.00109	0.00786	CcSEcCtD
Halofantrine—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00109	0.00782	CcSEcCtD
Halofantrine—Pollakiuria—Rivastigmine—Alzheimer's disease	0.00107	0.00769	CcSEcCtD
Halofantrine—Malaise—Galantamine—Alzheimer's disease	0.00106	0.0076	CcSEcCtD
Halofantrine—Palpitations—Galantamine—Alzheimer's disease	0.00104	0.00744	CcSEcCtD
Halofantrine—Cough—Galantamine—Alzheimer's disease	0.00102	0.00735	CcSEcCtD
Halofantrine—Convulsion—Galantamine—Alzheimer's disease	0.00102	0.0073	CcSEcCtD
Halofantrine—Visual impairment—Donepezil—Alzheimer's disease	0.00101	0.00723	CcSEcCtD
Halofantrine—Myalgia—Galantamine—Alzheimer's disease	0.000999	0.00717	CcSEcCtD
Halofantrine—Arthralgia—Galantamine—Alzheimer's disease	0.000999	0.00717	CcSEcCtD
Halofantrine—Chest pain—Galantamine—Alzheimer's disease	0.000999	0.00717	CcSEcCtD
Halofantrine—Discomfort—Galantamine—Alzheimer's disease	0.000987	0.00709	CcSEcCtD
Halofantrine—Tinnitus—Donepezil—Alzheimer's disease	0.000974	0.00699	CcSEcCtD
Halofantrine—Confusional state—Galantamine—Alzheimer's disease	0.000966	0.00693	CcSEcCtD
Halofantrine—Chills—Donepezil—Alzheimer's disease	0.000937	0.00673	CcSEcCtD
Halofantrine—Arrhythmia—Donepezil—Alzheimer's disease	0.000933	0.0067	CcSEcCtD
Halofantrine—Visual impairment—Memantine—Alzheimer's disease	0.000914	0.00656	CcSEcCtD
Halofantrine—Anorexia—Galantamine—Alzheimer's disease	0.000913	0.00655	CcSEcCtD
Halofantrine—Visual impairment—Rivastigmine—Alzheimer's disease	0.000894	0.00642	CcSEcCtD
Halofantrine—Tinnitus—Memantine—Alzheimer's disease	0.000884	0.00635	CcSEcCtD
Halofantrine—Back pain—Donepezil—Alzheimer's disease	0.00088	0.00631	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000873	0.00626	CcSEcCtD
Halofantrine—Tinnitus—Rivastigmine—Alzheimer's disease	0.000865	0.00621	CcSEcCtD
Halofantrine—Paraesthesia—Galantamine—Alzheimer's disease	0.00086	0.00617	CcSEcCtD
Halofantrine—Chills—Memantine—Alzheimer's disease	0.000851	0.00611	CcSEcCtD
Halofantrine—Arrhythmia—Memantine—Alzheimer's disease	0.000847	0.00608	CcSEcCtD
Halofantrine—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000844	0.00606	CcSEcCtD
Halofantrine—Dyspepsia—Galantamine—Alzheimer's disease	0.000843	0.00605	CcSEcCtD
Halofantrine—Chills—Rivastigmine—Alzheimer's disease	0.000833	0.00598	CcSEcCtD
Halofantrine—Decreased appetite—Galantamine—Alzheimer's disease	0.000832	0.00598	CcSEcCtD
Halofantrine—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000829	0.00595	CcSEcCtD
Halofantrine—Fatigue—Galantamine—Alzheimer's disease	0.000826	0.00593	CcSEcCtD
Halofantrine—Malaise—Donepezil—Alzheimer's disease	0.00082	0.00589	CcSEcCtD
Halofantrine—Constipation—Galantamine—Alzheimer's disease	0.000819	0.00588	CcSEcCtD
Halofantrine—Back pain—Memantine—Alzheimer's disease	0.000799	0.00573	CcSEcCtD
Halofantrine—Cough—Donepezil—Alzheimer's disease	0.000794	0.0057	CcSEcCtD
Halofantrine—Feeling abnormal—Galantamine—Alzheimer's disease	0.000789	0.00566	CcSEcCtD
Halofantrine—Convulsion—Donepezil—Alzheimer's disease	0.000788	0.00566	CcSEcCtD
Halofantrine—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000783	0.00562	CcSEcCtD
Halofantrine—Back pain—Rivastigmine—Alzheimer's disease	0.000781	0.00561	CcSEcCtD
Halofantrine—Myalgia—Donepezil—Alzheimer's disease	0.000774	0.00556	CcSEcCtD
Halofantrine—Arthralgia—Donepezil—Alzheimer's disease	0.000774	0.00556	CcSEcCtD
Halofantrine—Chest pain—Donepezil—Alzheimer's disease	0.000774	0.00556	CcSEcCtD
Halofantrine—Ill-defined disorder—Memantine—Alzheimer's disease	0.000766	0.0055	CcSEcCtD
Halofantrine—Discomfort—Donepezil—Alzheimer's disease	0.000765	0.00549	CcSEcCtD
Halofantrine—Abdominal pain—Galantamine—Alzheimer's disease	0.000757	0.00543	CcSEcCtD
Halofantrine—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000749	0.00538	CcSEcCtD
Halofantrine—Confusional state—Donepezil—Alzheimer's disease	0.000748	0.00537	CcSEcCtD
Halofantrine—Malaise—Memantine—Alzheimer's disease	0.000745	0.00534	CcSEcCtD
Halofantrine—Palpitations—Memantine—Alzheimer's disease	0.00073	0.00524	CcSEcCtD
Halofantrine—Malaise—Rivastigmine—Alzheimer's disease	0.000728	0.00523	CcSEcCtD
Halofantrine—Cough—Memantine—Alzheimer's disease	0.000721	0.00517	CcSEcCtD
Halofantrine—Convulsion—Memantine—Alzheimer's disease	0.000715	0.00514	CcSEcCtD
Halofantrine—Palpitations—Rivastigmine—Alzheimer's disease	0.000714	0.00512	CcSEcCtD
Halofantrine—Anorexia—Donepezil—Alzheimer's disease	0.000707	0.00508	CcSEcCtD
Halofantrine—Cough—Rivastigmine—Alzheimer's disease	0.000705	0.00506	CcSEcCtD
Halofantrine—Arthralgia—Memantine—Alzheimer's disease	0.000703	0.00505	CcSEcCtD
Halofantrine—Chest pain—Memantine—Alzheimer's disease	0.000703	0.00505	CcSEcCtD
Halofantrine—Myalgia—Memantine—Alzheimer's disease	0.000703	0.00505	CcSEcCtD
Halofantrine—Convulsion—Rivastigmine—Alzheimer's disease	0.0007	0.00502	CcSEcCtD
Halofantrine—Discomfort—Memantine—Alzheimer's disease	0.000695	0.00499	CcSEcCtD
Halofantrine—Arthralgia—Rivastigmine—Alzheimer's disease	0.000688	0.00494	CcSEcCtD
Halofantrine—Myalgia—Rivastigmine—Alzheimer's disease	0.000688	0.00494	CcSEcCtD
Halofantrine—Chest pain—Rivastigmine—Alzheimer's disease	0.000688	0.00494	CcSEcCtD
Halofantrine—Asthenia—Galantamine—Alzheimer's disease	0.000687	0.00493	CcSEcCtD
Halofantrine—Confusional state—Memantine—Alzheimer's disease	0.000679	0.00488	CcSEcCtD
Halofantrine—Discomfort—Rivastigmine—Alzheimer's disease	0.000679	0.00488	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000676	0.00485	CcSEcCtD
Halofantrine—Paraesthesia—Donepezil—Alzheimer's disease	0.000666	0.00478	CcSEcCtD
Halofantrine—Confusional state—Rivastigmine—Alzheimer's disease	0.000665	0.00477	CcSEcCtD
Halofantrine—Diarrhoea—Galantamine—Alzheimer's disease	0.000655	0.0047	CcSEcCtD
Halofantrine—Dyspepsia—Donepezil—Alzheimer's disease	0.000653	0.00469	CcSEcCtD
Halofantrine—Decreased appetite—Donepezil—Alzheimer's disease	0.000645	0.00463	CcSEcCtD
Halofantrine—Anorexia—Memantine—Alzheimer's disease	0.000642	0.00461	CcSEcCtD
Halofantrine—Fatigue—Donepezil—Alzheimer's disease	0.00064	0.00459	CcSEcCtD
Halofantrine—Constipation—Donepezil—Alzheimer's disease	0.000635	0.00456	CcSEcCtD
Halofantrine—Dizziness—Galantamine—Alzheimer's disease	0.000633	0.00455	CcSEcCtD
Halofantrine—Anorexia—Rivastigmine—Alzheimer's disease	0.000628	0.00451	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000614	0.00441	CcSEcCtD
Halofantrine—Feeling abnormal—Donepezil—Alzheimer's disease	0.000612	0.00439	CcSEcCtD
Halofantrine—Vomiting—Galantamine—Alzheimer's disease	0.000609	0.00437	CcSEcCtD
Halofantrine—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000607	0.00436	CcSEcCtD
Halofantrine—Paraesthesia—Memantine—Alzheimer's disease	0.000605	0.00434	CcSEcCtD
Halofantrine—Rash—Galantamine—Alzheimer's disease	0.000604	0.00433	CcSEcCtD
Halofantrine—Dermatitis—Galantamine—Alzheimer's disease	0.000603	0.00433	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000601	0.00431	CcSEcCtD
Halofantrine—Headache—Galantamine—Alzheimer's disease	0.0006	0.00431	CcSEcCtD
Halofantrine—Dyspepsia—Memantine—Alzheimer's disease	0.000593	0.00426	CcSEcCtD
Halofantrine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000592	0.00425	CcSEcCtD
Halofantrine—Urticaria—Donepezil—Alzheimer's disease	0.00059	0.00423	CcSEcCtD
Halofantrine—Abdominal pain—Donepezil—Alzheimer's disease	0.000587	0.00421	CcSEcCtD
Halofantrine—Decreased appetite—Memantine—Alzheimer's disease	0.000586	0.00421	CcSEcCtD
Halofantrine—Fatigue—Memantine—Alzheimer's disease	0.000581	0.00417	CcSEcCtD
Halofantrine—Dyspepsia—Rivastigmine—Alzheimer's disease	0.00058	0.00417	CcSEcCtD
Halofantrine—Constipation—Memantine—Alzheimer's disease	0.000576	0.00414	CcSEcCtD
Halofantrine—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000573	0.00411	CcSEcCtD
Halofantrine—Nausea—Galantamine—Alzheimer's disease	0.000569	0.00408	CcSEcCtD
Halofantrine—Fatigue—Rivastigmine—Alzheimer's disease	0.000568	0.00408	CcSEcCtD
Halofantrine—Constipation—Rivastigmine—Alzheimer's disease	0.000564	0.00405	CcSEcCtD
Halofantrine—Feeling abnormal—Memantine—Alzheimer's disease	0.000555	0.00399	CcSEcCtD
Halofantrine—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000551	0.00396	CcSEcCtD
Halofantrine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000543	0.0039	CcSEcCtD
Halofantrine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000539	0.00387	CcSEcCtD
Halofantrine—Urticaria—Memantine—Alzheimer's disease	0.000535	0.00384	CcSEcCtD
Halofantrine—Abdominal pain—Memantine—Alzheimer's disease	0.000533	0.00382	CcSEcCtD
Halofantrine—Asthenia—Donepezil—Alzheimer's disease	0.000532	0.00382	CcSEcCtD
Halofantrine—Pruritus—Donepezil—Alzheimer's disease	0.000525	0.00377	CcSEcCtD
Halofantrine—Urticaria—Rivastigmine—Alzheimer's disease	0.000524	0.00376	CcSEcCtD
Halofantrine—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000521	0.00374	CcSEcCtD
Halofantrine—Diarrhoea—Donepezil—Alzheimer's disease	0.000508	0.00365	CcSEcCtD
Halofantrine—Dizziness—Donepezil—Alzheimer's disease	0.000491	0.00352	CcSEcCtD
Halofantrine—Asthenia—Memantine—Alzheimer's disease	0.000483	0.00347	CcSEcCtD
Halofantrine—Pruritus—Memantine—Alzheimer's disease	0.000477	0.00342	CcSEcCtD
Halofantrine—Asthenia—Rivastigmine—Alzheimer's disease	0.000473	0.0034	CcSEcCtD
Halofantrine—Vomiting—Donepezil—Alzheimer's disease	0.000472	0.00339	CcSEcCtD
Halofantrine—Rash—Donepezil—Alzheimer's disease	0.000468	0.00336	CcSEcCtD
Halofantrine—Dermatitis—Donepezil—Alzheimer's disease	0.000468	0.00336	CcSEcCtD
Halofantrine—Pruritus—Rivastigmine—Alzheimer's disease	0.000466	0.00335	CcSEcCtD
Halofantrine—Headache—Donepezil—Alzheimer's disease	0.000465	0.00334	CcSEcCtD
Halofantrine—Diarrhoea—Memantine—Alzheimer's disease	0.000461	0.00331	CcSEcCtD
Halofantrine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000451	0.00324	CcSEcCtD
Halofantrine—Dizziness—Memantine—Alzheimer's disease	0.000446	0.0032	CcSEcCtD
Halofantrine—Nausea—Donepezil—Alzheimer's disease	0.000441	0.00316	CcSEcCtD
Halofantrine—Dizziness—Rivastigmine—Alzheimer's disease	0.000436	0.00313	CcSEcCtD
Halofantrine—Vomiting—Memantine—Alzheimer's disease	0.000428	0.00308	CcSEcCtD
Halofantrine—Rash—Memantine—Alzheimer's disease	0.000425	0.00305	CcSEcCtD
Halofantrine—Dermatitis—Memantine—Alzheimer's disease	0.000424	0.00305	CcSEcCtD
Halofantrine—Headache—Memantine—Alzheimer's disease	0.000422	0.00303	CcSEcCtD
Halofantrine—Vomiting—Rivastigmine—Alzheimer's disease	0.000419	0.00301	CcSEcCtD
Halofantrine—Rash—Rivastigmine—Alzheimer's disease	0.000416	0.00298	CcSEcCtD
Halofantrine—Dermatitis—Rivastigmine—Alzheimer's disease	0.000415	0.00298	CcSEcCtD
Halofantrine—Headache—Rivastigmine—Alzheimer's disease	0.000413	0.00296	CcSEcCtD
Halofantrine—Nausea—Memantine—Alzheimer's disease	0.0004	0.00287	CcSEcCtD
Halofantrine—Nausea—Rivastigmine—Alzheimer's disease	0.000392	0.00281	CcSEcCtD
Halofantrine—KCNH2—Hematopoietic Stem Cell Differentiation—NOTCH1—Alzheimer's disease	0.000153	0.0116	CbGpPWpGaD
Halofantrine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.000152	0.0115	CbGpPWpGaD
Halofantrine—CYP2C8—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.00015	0.0114	CbGpPWpGaD
Halofantrine—CYP2D6—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.00015	0.0114	CbGpPWpGaD
Halofantrine—KCNH2—Neuronal System—SLC18A3—Alzheimer's disease	0.000144	0.0109	CbGpPWpGaD
Halofantrine—KCNH2—SIDS Susceptibility Pathways—CHAT—Alzheimer's disease	0.000137	0.0104	CbGpPWpGaD
Halofantrine—CYP3A4—Irinotecan Pathway—BCHE—Alzheimer's disease	0.000134	0.0102	CbGpPWpGaD
Halofantrine—CYP2D6—Melatonin metabolism and effects—ACHE—Alzheimer's disease	0.000132	0.00997	CbGpPWpGaD
Halofantrine—KCNH2—SIDS Susceptibility Pathways—HSPD1—Alzheimer's disease	0.000129	0.00979	CbGpPWpGaD
Halofantrine—CYP3A4—Tryptophan metabolism—HSD17B10—Alzheimer's disease	0.000128	0.0097	CbGpPWpGaD
Halofantrine—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Alzheimer's disease	0.000127	0.00964	CbGpPWpGaD
Halofantrine—KCNH2—SIDS Susceptibility Pathways—GAPDH—Alzheimer's disease	0.000127	0.00961	CbGpPWpGaD
Halofantrine—CYP2D6—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.000124	0.00936	CbGpPWpGaD
Halofantrine—CYP3A5—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	0.000117	0.0089	CbGpPWpGaD
Halofantrine—KCNH2—SIDS Susceptibility Pathways—CHRNB2—Alzheimer's disease	0.000116	0.00879	CbGpPWpGaD
Halofantrine—CYP3A4—Xenobiotics—CYP2D6—Alzheimer's disease	0.000106	0.00806	CbGpPWpGaD
Halofantrine—KCNH2—Hematopoietic Stem Cell Differentiation—IL1B—Alzheimer's disease	0.000106	0.00802	CbGpPWpGaD
Halofantrine—KCNH2—SIDS Susceptibility Pathways—CHRNA4—Alzheimer's disease	0.000105	0.00798	CbGpPWpGaD
Halofantrine—KCNH2—SIDS Susceptibility Pathways—TF—Alzheimer's disease	0.000104	0.00789	CbGpPWpGaD
Halofantrine—CYP3A5—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000104	0.00786	CbGpPWpGaD
Halofantrine—CYP3A4—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	0.000102	0.00776	CbGpPWpGaD
Halofantrine—KCNH2—Neuronal System—CHRNA7—Alzheimer's disease	0.000102	0.00769	CbGpPWpGaD
Halofantrine—KCNH2—Neuronal System—GRIK1—Alzheimer's disease	0.000102	0.00769	CbGpPWpGaD
Halofantrine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	9.96e-05	0.00755	CbGpPWpGaD
Halofantrine—CYP3A4—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	9.83e-05	0.00745	CbGpPWpGaD
Halofantrine—KCNH2—SIDS Susceptibility Pathways—SLC6A4—Alzheimer's disease	9.79e-05	0.00742	CbGpPWpGaD
Halofantrine—CYP2C8—Arachidonic acid metabolism—PTGS1—Alzheimer's disease	9.71e-05	0.00736	CbGpPWpGaD
Halofantrine—KCNH2—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	9.53e-05	0.00722	CbGpPWpGaD
Halofantrine—KCNH2—SIDS Susceptibility Pathways—SST—Alzheimer's disease	9.53e-05	0.00722	CbGpPWpGaD
Halofantrine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	9.5e-05	0.0072	CbGpPWpGaD
Halofantrine—CYP3A5—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	9.38e-05	0.00711	CbGpPWpGaD
Halofantrine—CYP3A5—Biological oxidations—CYP46A1—Alzheimer's disease	9.23e-05	0.00699	CbGpPWpGaD
Halofantrine—CYP3A5—Metapathway biotransformation—CYP46A1—Alzheimer's disease	9.1e-05	0.0069	CbGpPWpGaD
Halofantrine—CYP2C8—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	8.98e-05	0.0068	CbGpPWpGaD
Halofantrine—KCNH2—Neuronal System—CHAT—Alzheimer's disease	8.63e-05	0.00654	CbGpPWpGaD
Halofantrine—KCNH2—Neuronal System—GRIK2—Alzheimer's disease	8.63e-05	0.00654	CbGpPWpGaD
Halofantrine—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—Alzheimer's disease	8.29e-05	0.00628	CbGpPWpGaD
Halofantrine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	8.23e-05	0.00624	CbGpPWpGaD
Halofantrine—CYP2C8—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	8.12e-05	0.00616	CbGpPWpGaD
Halofantrine—CYP3A4—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	8.08e-05	0.00612	CbGpPWpGaD
Halofantrine—CYP2C8—Biological oxidations—CYP46A1—Alzheimer's disease	7.99e-05	0.00606	CbGpPWpGaD
Halofantrine—CYP2C8—Metapathway biotransformation—CYP46A1—Alzheimer's disease	7.88e-05	0.00597	CbGpPWpGaD
Halofantrine—CYP3A5—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	7.86e-05	0.00595	CbGpPWpGaD
Halofantrine—CYP3A5—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	7.71e-05	0.00584	CbGpPWpGaD
Halofantrine—KCNH2—Neuronal System—GRIA1—Alzheimer's disease	7.7e-05	0.00583	CbGpPWpGaD
Halofantrine—CYP2D6—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	7.37e-05	0.00559	CbGpPWpGaD
Halofantrine—CYP3A4—Tryptophan metabolism—MAOB—Alzheimer's disease	7.35e-05	0.00557	CbGpPWpGaD
Halofantrine—KCNH2—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	7.32e-05	0.00555	CbGpPWpGaD
Halofantrine—KCNH2—Neuronal System—CHRNB2—Alzheimer's disease	7.29e-05	0.00552	CbGpPWpGaD
Halofantrine—KCNH2—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	7.11e-05	0.00539	CbGpPWpGaD
Halofantrine—CYP2D6—Melatonin metabolism and effects—CALM1—Alzheimer's disease	6.92e-05	0.00524	CbGpPWpGaD
Halofantrine—CYP2D6—Melatonin metabolism and effects—APOE—Alzheimer's disease	6.9e-05	0.00523	CbGpPWpGaD
Halofantrine—KCNH2—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	6.83e-05	0.00517	CbGpPWpGaD
Halofantrine—CYP2C8—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	6.81e-05	0.00516	CbGpPWpGaD
Halofantrine—KCNH2—Neuronal System—ACHE—Alzheimer's disease	6.69e-05	0.00507	CbGpPWpGaD
Halofantrine—CYP2C8—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	6.67e-05	0.00506	CbGpPWpGaD
Halofantrine—KCNH2—Neuronal System—CHRNA4—Alzheimer's disease	6.62e-05	0.00501	CbGpPWpGaD
Halofantrine—KCNH2—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	6.6e-05	0.005	CbGpPWpGaD
Halofantrine—CYP2D6—Biological oxidations—CYP46A1—Alzheimer's disease	6.56e-05	0.00497	CbGpPWpGaD
Halofantrine—CYP2D6—Metapathway biotransformation—CYP46A1—Alzheimer's disease	6.47e-05	0.00491	CbGpPWpGaD
Halofantrine—KCNH2—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	6.31e-05	0.00478	CbGpPWpGaD
Halofantrine—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—Alzheimer's disease	6.19e-05	0.00469	CbGpPWpGaD
Halofantrine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	6.03e-05	0.00457	CbGpPWpGaD
Halofantrine—KCNH2—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	6.01e-05	0.00455	CbGpPWpGaD
Halofantrine—CYP2D6—Melatonin metabolism and effects—GSK3B—Alzheimer's disease	5.97e-05	0.00453	CbGpPWpGaD
Halofantrine—KCNH2—Neuronal System—BCHE—Alzheimer's disease	5.83e-05	0.00442	CbGpPWpGaD
Halofantrine—KCNH2—Neuronal System—DLG4—Alzheimer's disease	5.69e-05	0.00431	CbGpPWpGaD
Halofantrine—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	5.59e-05	0.00423	CbGpPWpGaD
Halofantrine—KCNH2—Neuronal System—GRIN2B—Alzheimer's disease	5.56e-05	0.00422	CbGpPWpGaD
Halofantrine—CYP3A5—Biological oxidations—MAOB—Alzheimer's disease	5.51e-05	0.00417	CbGpPWpGaD
Halofantrine—KCNH2—Neuronal System—PLCB1—Alzheimer's disease	5.5e-05	0.00417	CbGpPWpGaD
Halofantrine—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	5.46e-05	0.00414	CbGpPWpGaD
Halofantrine—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	4.82e-05	0.00365	CbGpPWpGaD
Halofantrine—KCNH2—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	4.8e-05	0.00364	CbGpPWpGaD
Halofantrine—CYP2C8—Biological oxidations—MAOB—Alzheimer's disease	4.77e-05	0.00361	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	4.6e-05	0.00349	CbGpPWpGaD
Halofantrine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	4.42e-05	0.00335	CbGpPWpGaD
Halofantrine—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	4.36e-05	0.0033	CbGpPWpGaD
Halofantrine—CYP3A4—Biological oxidations—CYP46A1—Alzheimer's disease	4.29e-05	0.00325	CbGpPWpGaD
Halofantrine—CYP3A4—Metapathway biotransformation—CYP46A1—Alzheimer's disease	4.23e-05	0.00321	CbGpPWpGaD
Halofantrine—CYP3A5—Biological oxidations—PTGS1—Alzheimer's disease	4.17e-05	0.00316	CbGpPWpGaD
Halofantrine—CYP3A5—Biological oxidations—CYP2D6—Alzheimer's disease	4.09e-05	0.0031	CbGpPWpGaD
Halofantrine—KCNH2—Neuronal System—PRKCG—Alzheimer's disease	4.07e-05	0.00308	CbGpPWpGaD
Halofantrine—CYP3A5—Metapathway biotransformation—CYP2D6—Alzheimer's disease	4.04e-05	0.00306	CbGpPWpGaD
Halofantrine—CYP2D6—Biological oxidations—MAOB—Alzheimer's disease	3.92e-05	0.00297	CbGpPWpGaD
Halofantrine—CYP2C8—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	3.72e-05	0.00282	CbGpPWpGaD
Halofantrine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	3.65e-05	0.00277	CbGpPWpGaD
Halofantrine—CYP2C8—Biological oxidations—PTGS1—Alzheimer's disease	3.61e-05	0.00274	CbGpPWpGaD
Halofantrine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	3.58e-05	0.00271	CbGpPWpGaD
Halofantrine—KCNH2—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	3.56e-05	0.0027	CbGpPWpGaD
Halofantrine—KCNH2—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	3.55e-05	0.00269	CbGpPWpGaD
Halofantrine—CYP2C8—Biological oxidations—CYP2D6—Alzheimer's disease	3.55e-05	0.00269	CbGpPWpGaD
Halofantrine—KCNH2—Neuronal System—CALM1—Alzheimer's disease	3.52e-05	0.00267	CbGpPWpGaD
Halofantrine—CYP2C8—Metapathway biotransformation—CYP2D6—Alzheimer's disease	3.5e-05	0.00265	CbGpPWpGaD
Halofantrine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	3.46e-05	0.00262	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	3.33e-05	0.00252	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	3.07e-05	0.00233	CbGpPWpGaD
Halofantrine—KCNH2—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	3.01e-05	0.00228	CbGpPWpGaD
Halofantrine—KCNH2—Neuronal System—CREB1—Alzheimer's disease	3.01e-05	0.00228	CbGpPWpGaD
Halofantrine—CYP2D6—Biological oxidations—PTGS1—Alzheimer's disease	2.97e-05	0.00225	CbGpPWpGaD
Halofantrine—KCNH2—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	2.58e-05	0.00196	CbGpPWpGaD
Halofantrine—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	2.56e-05	0.00194	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—DHCR24—Alzheimer's disease	2.37e-05	0.00179	CbGpPWpGaD
Halofantrine—KCNH2—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	2.09e-05	0.00158	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—DHCR24—Alzheimer's disease	2.05e-05	0.00155	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CA4—Alzheimer's disease	2.01e-05	0.00152	CbGpPWpGaD
Halofantrine—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	1.94e-05	0.00147	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	1.91e-05	0.00145	CbGpPWpGaD
Halofantrine—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	1.9e-05	0.00144	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GAPDHS—Alzheimer's disease	1.89e-05	0.00143	CbGpPWpGaD
Halofantrine—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	1.88e-05	0.00142	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ATP5A1—Alzheimer's disease	1.79e-05	0.00136	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CA4—Alzheimer's disease	1.74e-05	0.00132	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PLD3—Alzheimer's disease	1.71e-05	0.0013	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	1.7e-05	0.00129	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—DHCR24—Alzheimer's disease	1.68e-05	0.00127	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—HSD17B10—Alzheimer's disease	1.64e-05	0.00124	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GAPDHS—Alzheimer's disease	1.64e-05	0.00124	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CYP46A1—Alzheimer's disease	1.58e-05	0.0012	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ATP5A1—Alzheimer's disease	1.55e-05	0.00118	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ND1—Alzheimer's disease	1.52e-05	0.00116	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PLD3—Alzheimer's disease	1.48e-05	0.00112	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	1.48e-05	0.00112	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	1.46e-05	0.00111	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CA4—Alzheimer's disease	1.43e-05	0.00108	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—HSD17B10—Alzheimer's disease	1.42e-05	0.00108	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	1.39e-05	0.00105	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CYP46A1—Alzheimer's disease	1.37e-05	0.00104	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GAPDHS—Alzheimer's disease	1.34e-05	0.00102	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ND1—Alzheimer's disease	1.32e-05	0.001	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.29e-05	0.000978	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ATP5A1—Alzheimer's disease	1.27e-05	0.000966	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PLD3—Alzheimer's disease	1.22e-05	0.000922	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.18e-05	0.000894	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—HSD17B10—Alzheimer's disease	1.17e-05	0.000884	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CYP46A1—Alzheimer's disease	1.12e-05	0.000851	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	1.1e-05	0.000833	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ND1—Alzheimer's disease	1.08e-05	0.000821	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.02e-05	0.000771	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—TPI1—Alzheimer's disease	9.82e-06	0.000744	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CHAT—Alzheimer's disease	9.82e-06	0.000744	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—MAOB—Alzheimer's disease	9.42e-06	0.000714	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CA4—Alzheimer's disease	9.35e-06	0.000709	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	9.26e-06	0.000702	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GAPDH—Alzheimer's disease	9.07e-06	0.000687	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	8.79e-06	0.000666	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—A2M—Alzheimer's disease	8.76e-06	0.000663	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—TPI1—Alzheimer's disease	8.51e-06	0.000645	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CHAT—Alzheimer's disease	8.51e-06	0.000645	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	8.33e-06	0.000632	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—MAOB—Alzheimer's disease	8.16e-06	0.000618	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PLD3—Alzheimer's disease	7.95e-06	0.000603	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GAPDH—Alzheimer's disease	7.85e-06	0.000595	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	7.76e-06	0.000588	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	7.69e-06	0.000583	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	7.62e-06	0.000578	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ACHE—Alzheimer's disease	7.62e-06	0.000577	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—A2M—Alzheimer's disease	7.58e-06	0.000575	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—INPP5D—Alzheimer's disease	7.53e-06	0.000571	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	7.34e-06	0.000556	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ENO1—Alzheimer's disease	7.14e-06	0.000541	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PTGS1—Alzheimer's disease	7.14e-06	0.000541	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ND1—Alzheimer's disease	7.09e-06	0.000537	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CYP2D6—Alzheimer's disease	7e-06	0.00053	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—TPI1—Alzheimer's disease	6.99e-06	0.000529	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CHAT—Alzheimer's disease	6.99e-06	0.000529	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	6.76e-06	0.000512	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—MAOB—Alzheimer's disease	6.7e-06	0.000507	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—BCHE—Alzheimer's disease	6.64e-06	0.000503	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ACHE—Alzheimer's disease	6.6e-06	0.0005	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—INPP5D—Alzheimer's disease	6.52e-06	0.000494	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	6.45e-06	0.000489	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PLCB1—Alzheimer's disease	6.26e-06	0.000474	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—A2M—Alzheimer's disease	6.23e-06	0.000472	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PTGS1—Alzheimer's disease	6.18e-06	0.000468	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ENO1—Alzheimer's disease	6.18e-06	0.000468	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ABCA1—Alzheimer's disease	6.07e-06	0.00046	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CYP2D6—Alzheimer's disease	6.06e-06	0.000459	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—BCHE—Alzheimer's disease	5.75e-06	0.000436	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PLCB1—Alzheimer's disease	5.42e-06	0.000411	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ACHE—Alzheimer's disease	5.42e-06	0.00041	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	5.35e-06	0.000406	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	5.32e-06	0.000403	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ABCA1—Alzheimer's disease	5.26e-06	0.000398	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PPARGC1A—Alzheimer's disease	5.23e-06	0.000396	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—HMOX1—Alzheimer's disease	5.21e-06	0.000395	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ENO1—Alzheimer's disease	5.08e-06	0.000385	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	5.08e-06	0.000385	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—LPL—Alzheimer's disease	4.76e-06	0.000361	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—BCHE—Alzheimer's disease	4.72e-06	0.000358	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—TPI1—Alzheimer's disease	4.57e-06	0.000346	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CHAT—Alzheimer's disease	4.57e-06	0.000346	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PPARGC1A—Alzheimer's disease	4.53e-06	0.000343	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—HMOX1—Alzheimer's disease	4.51e-06	0.000342	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	4.45e-06	0.000337	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—MAOB—Alzheimer's disease	4.38e-06	0.000332	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	4.32e-06	0.000327	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—MTHFR—Alzheimer's disease	4.29e-06	0.000325	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	4.21e-06	0.000319	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—LPL—Alzheimer's disease	4.12e-06	0.000313	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—A2M—Alzheimer's disease	4.07e-06	0.000308	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CALM1—Alzheimer's disease	4.01e-06	0.000304	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—APOE—Alzheimer's disease	3.99e-06	0.000302	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CAV1—Alzheimer's disease	3.96e-06	0.0003	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	3.72e-06	0.000282	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—MTHFR—Alzheimer's disease	3.71e-06	0.000281	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	3.7e-06	0.000281	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ACHE—Alzheimer's disease	3.54e-06	0.000268	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	3.5e-06	0.000265	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PPARG—Alzheimer's disease	3.48e-06	0.000263	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CALM1—Alzheimer's disease	3.47e-06	0.000263	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—APOE—Alzheimer's disease	3.46e-06	0.000262	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CAV1—Alzheimer's disease	3.43e-06	0.00026	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—INS—Alzheimer's disease	3.41e-06	0.000258	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—LPL—Alzheimer's disease	3.39e-06	0.000257	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	3.32e-06	0.000251	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	3.32e-06	0.000251	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	3.25e-06	0.000247	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	3.08e-06	0.000234	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	3.05e-06	0.000231	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PPARG—Alzheimer's disease	3.01e-06	0.000228	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—NOS3—Alzheimer's disease	2.99e-06	0.000227	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—INS—Alzheimer's disease	2.95e-06	0.000224	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	2.91e-06	0.000221	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CALM1—Alzheimer's disease	2.85e-06	0.000216	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—APOE—Alzheimer's disease	2.84e-06	0.000215	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	2.82e-06	0.000214	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CAV1—Alzheimer's disease	2.81e-06	0.000213	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	2.74e-06	0.000207	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—NOS3—Alzheimer's disease	2.59e-06	0.000196	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PPARG—Alzheimer's disease	2.47e-06	0.000187	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	2.43e-06	0.000184	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—INS—Alzheimer's disease	2.42e-06	0.000184	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	2.42e-06	0.000183	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PTGS2—Alzheimer's disease	2.37e-06	0.00018	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—LPL—Alzheimer's disease	2.21e-06	0.000168	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—NOS3—Alzheimer's disease	2.13e-06	0.000161	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.99e-06	0.000151	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	1.94e-06	0.000147	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1.86e-06	0.000141	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—APOE—Alzheimer's disease	1.86e-06	0.000141	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	1.84e-06	0.000139	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	1.62e-06	0.000122	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—INS—Alzheimer's disease	1.59e-06	0.00012	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.39e-06	0.000105	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—AKT1—Alzheimer's disease	1.37e-06	0.000104	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.27e-06	9.64e-05	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—AKT1—Alzheimer's disease	1.19e-06	9.02e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—AKT1—Alzheimer's disease	9.78e-07	7.41e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	6.39e-07	4.84e-05	CbGpPWpGaD
